On April 6, 2026, Oncolytics Biotech Inc. (the "Company") entered into an Open Market Sale Agreement (the "Sales Agreement") with Jefferies LLC (the "Agent"), pursuant to which the Company may offer and sell from time to time through or to the agent, acting as agent or principal, shares of the Company's common stock, par value $0.001 per share, having an aggregate offering price of up to $75.0 million (the "Shares").